Results 81 to 90 of about 65,110 (152)

Glucagon-like peptide-1 receptor agonists and rotator cuff disease: a scoping review. [PDF]

BMC Musculoskelet Disord
Duru DO, Zhou AK, Lee DKR, Carroll PJ, Elmaraghy A.   +4 more
europepmc   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Anaesthesia Considerations

Airway
Hemlata Kapoor, Dheeraj Kapoor
doaj   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists and Reproductive Health: A Narrative Review for Obstetrician-Gynecologists. [PDF]

Cureus
Almaradweh S, Mousa E.
europepmc   +1 more source

Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia. [PDF]

Obes Pillars
Kalagi F, Bah S, Algindan Y.
europepmc   +1 more source

Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes. [PDF]

Dermatol Ther (Heidelb)
Piraccini BM, Vañó-Galván S, Blume-Peytavi U, Ribet V, Mengeaud V.   +4 more
europepmc   +1 more source

Metabolic Modulation in Cancer Care: The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists. [PDF]

J Clin Oncol
Temperley HC, Kelly ME.
europepmc   +1 more source

Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis. [PDF]

BMJ Open
Tang B, Yu Y, Tang Y, Yu R, Liu X.
europepmc   +1 more source